C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
1.580
+0.110 (7.48%)
At close: May 12, 2025, 4:00 PM
1.570
-0.010 (-0.64%)
After-hours: May 12, 2025, 7:22 PM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $112.19 million as of May 12, 2025. Its market cap has decreased by -74.72% in one year.
Market Cap
112.19M
Enterprise Value
-58.15M
1-Year Change
-74.72%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $112.19M, a decrease of -85.48%. That is a compound annual growth rate of -34.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 104.38M | -58.92% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | 1.43B | 84.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |